Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Overview of qualitative leukocyte morphological changes observed in blood films at initial sampling from 27 elephants with inflammatory conditions.

More »

Table 1 Expand

Fig 1.

Normal morphology of elephant leukocytes.

1: Mature heterophil, 2: Mature heterophil with Barr body in a female elephant (sex chromatin lobe), 3–4: eosinophils, 5–6: basophils, 7–8: small lymphocytes, 9: monocyte, 10–20: unique monocyte type of elephants with various stages of segmentation; note that less segmented monocytes may be misidentified as lymphocytes. 21–25: degenerative changes in leukocytes in blood films prepared 24 hr after collection, including 21: heterophil with nuclear and cytoplasmic swelling, 22: monocyte with swollen nucleus, 23–25: karyorrhexis and pyknosis in leukocytes. X100 objective. Wright Giemsa stain.

More »

Fig 1 Expand

Fig 2.

Abnormal morphology of elephant leukocytes.

Legend: 1–2: Band heterophils, 3: heterophilic myelocyte, 4–6: hypersegmented heterophils, 7–16: reactive lymphocytes, 17: plasma cell, 18–25: activated monocytes with variable vacuolation. X100 objective. Wright Giemsa stain.

More »

Fig 2 Expand

Fig 3.

Heterophil left-shifting and variable toxicity in elephant blood films.

1–6: Mature heterophils, 7–12: band heterophils, 13–20: heterophilic metamyelocytes, 21–25: heterophilic myelocytes. Grading of toxicity on a scale of 1+ (Doehle bodies, slight basophilia), 2+ (Doehle bodies, moderate basophilia), and 3+ (cytoplasmic foaminess (dark blue cytoplasm, Doehle bodies may or may not be visible) [4]. 1+ toxicity is present in 1, 7; 2+ toxicity is present in 2, 3, 8, 10, 13–15, 17–19, 22–24; 3+ toxicity is present in 4–6, 9, 11–12, 16, 20–21, 25. X100 objective. Wright Giemsa stain.

More »

Fig 3 Expand

Fig 4.

Heterophil left-shifting and variably toxicity in an Asian elephant with gastrointestinal disease for demonstration of the size variation from concurrent secondary dysgranulopoiesis (giant cells).

X100 objective. Wright Giemsa stain.

More »

Fig 4 Expand